587 related articles for article (PubMed ID: 27103470)
1. Myasthenia gravis - autoantibody characteristics and their implications for therapy.
Gilhus NE; Skeie GO; Romi F; Lazaridis K; Zisimopoulou P; Tzartos S
Nat Rev Neurol; 2016 May; 12(5):259-68. PubMed ID: 27103470
[TBL] [Abstract][Full Text] [Related]
2. [Myasthenia gravis and autoantibodies: Pathophysiology of the different subtypes].
Berrih-Aknin S; Le Panse R
Rev Med Interne; 2014 Jul; 35(7):413-20. PubMed ID: 24156976
[TBL] [Abstract][Full Text] [Related]
3. Myasthenia gravis: subgroup classification and therapeutic strategies.
Gilhus NE; Verschuuren JJ
Lancet Neurol; 2015 Oct; 14(10):1023-36. PubMed ID: 26376969
[TBL] [Abstract][Full Text] [Related]
4. Myasthenia and the neuromuscular junction.
Gilhus NE
Curr Opin Neurol; 2012 Oct; 25(5):523-9. PubMed ID: 22892950
[TBL] [Abstract][Full Text] [Related]
5. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and clinical classification of autoimmune myasthenia gravis.
Berrih-Aknin S; Frenkian-Cuvelier M; Eymard B
J Autoimmun; 2014; 48-49():143-8. PubMed ID: 24530233
[TBL] [Abstract][Full Text] [Related]
7. Seronegative myasthenia gravis.
Vincent A; McConville J; Farrugia ME; Newsom-Davis J
Semin Neurol; 2004 Mar; 24(1):125-33. PubMed ID: 15229799
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiology and immunological profile of myasthenia gravis and its subgroups.
Romi F; Hong Y; Gilhus NE
Curr Opin Immunol; 2017 Dec; 49():9-13. PubMed ID: 28780294
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
Sanadze AG; Sidnev DV; Karganov MIu
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
[TBL] [Abstract][Full Text] [Related]
10. Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine.
Sabre L; Punga T; Punga AR
Front Immunol; 2020; 11():213. PubMed ID: 32194544
[TBL] [Abstract][Full Text] [Related]
11. [An update on myasthenia gravis].
Martínez Torre S; Gómez Molinero I; Martínez Girón R
Semergen; 2018; 44(5):351-354. PubMed ID: 29555378
[TBL] [Abstract][Full Text] [Related]
12. Pathogenic immune mechanisms at the neuromuscular synapse: the role of specific antibody-binding epitopes in myasthenia gravis.
Huijbers MG; Lipka AF; Plomp JJ; Niks EH; van der Maarel SM; Verschuuren JJ
J Intern Med; 2014 Jan; 275(1):12-26. PubMed ID: 24215230
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies to Low-Density Lipoprotein Receptor-Related Protein 4 in Double Seronegative Myasthenia Gravis: A Systematic Review.
Bacchi S; Kramer P; Chalk C
Can J Neurol Sci; 2018 Jan; 45(1):62-67. PubMed ID: 29334041
[TBL] [Abstract][Full Text] [Related]
14. Insights in the autoimmunity of myasthenia gravis.
De Baets MH
Autoimmunity; 2010 Aug; 43(5-6):341-3. PubMed ID: 20380585
[TBL] [Abstract][Full Text] [Related]
15. Antibody effector mechanisms in myasthenia gravis-pathogenesis at the neuromuscular junction.
Gomez AM; Van Den Broeck J; Vrolix K; Janssen SP; Lemmens MA; Van Der Esch E; Duimel H; Frederik P; Molenaar PC; Martínez-Martínez P; De Baets MH; Losen M
Autoimmunity; 2010 Aug; 43(5-6):353-70. PubMed ID: 20380584
[TBL] [Abstract][Full Text] [Related]
16. [Pseudo-internuclear ophthalmoplegia in myasthenia gravis].
Bogdan I; Crisanda V
Oftalmologia; 2011; 55(3):70-3. PubMed ID: 22428294
[TBL] [Abstract][Full Text] [Related]
17. Autoimmune myasthenia gravis: autoantibody mechanisms and new developments on immune regulation.
Le Panse R; Berrih-Aknin S
Curr Opin Neurol; 2013 Oct; 26(5):569-76. PubMed ID: 23995274
[TBL] [Abstract][Full Text] [Related]
18. [Therapeutic strategy in myasthenia gravis].
Tranchant C
Rev Neurol (Paris); 2009 Feb; 165(2):149-54. PubMed ID: 19233080
[TBL] [Abstract][Full Text] [Related]
19. Myasthenia gravis and the neuromuscular junction.
Querol L; Illa I
Curr Opin Neurol; 2013 Oct; 26(5):459-65. PubMed ID: 23945282
[TBL] [Abstract][Full Text] [Related]
20. A Neurologist's Perspective on Understanding Myasthenia Gravis: Clinical Perspectives of Etiologic Factors, Diagnosis, and Preoperative Treatment.
Mukharesh L; Kaminski HJ
Thorac Surg Clin; 2019 May; 29(2):133-141. PubMed ID: 30927994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
